BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-205@pharmaconomics
DTSTAMP:20260707T015256Z
DTSTART;VALUE=DATE:20261114
DTEND;VALUE=DATE:20261115
SUMMARY:BTAI PDUFA — IGALMI
DESCRIPTION:The FDA's approval decision on IGALMI for agitation associated with bipolar disorders or schizophrenia is due Nov 14\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1720893/000110465926061773/tm2614679d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/205
URL:https://pharmaconomics.com/e/205
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:BTAI catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR